The dataset will be open from day one.
Anonymized CSV — starting value, latest value, months on platform, condition, city tier. Updated monthly once it exists. Email info@aarogyaassist.com to be notified when the first batch ships.
We're building Aarogya for the other 85% — and for the family members who get the panicked phone call after.
Aarogya is pre-launch. There are no beta users, no 312-person cohort, no improvement averages we can show — and we’d rather say that than fake a number. When real users start dropping reports, we’ll publish the outcomes here, with raw data anyone can audit.
Anonymized CSV. Starting value, latest value, months on platform. Updated monthly.
Independently validated “did this make sense?” rating per translated report. Broken down by language.
Did our reminders actually nudge people back to the lab on time? Compared against national averages.
Want to be one of the first users we measure? Email info@aarogyaassist.com.
Prevalence figures from ICMR-INDIAB (2024) and NFHS-5. We’ve picked the four conditions because they’re where families spend the most time reading and re-reading lab values — and where plain-language insights would help most.
When real users sign up, we’ll ask separately if they want to be part of an outcomes cohort. Nothing flows into the dataset by default. Withdraw any time — the row goes with you.
HbA1c for T2 diabetes. Systolic BP for hypertension. TSH for thyroid. Baseline is the report uploaded at signup. “Latest” is the most recent reading within the last 60 days.
Self-selection bias is real — opt-in users are more motivated than average. We’ll publish what we see as a signal, not as proof. And we’ll publish the failures too: what didn’t move, what got worse.
Bank-grade encryption. DPDP-compliant. ABDM-ready. The business model is the subscription — not your blood work.
After that, ₹129/month. No trial games. Cancel from settings — we don't hide the button.